"Compared to the reality of the drug industry, my book reads like a vacation post card"
- John le Carré, Author of The Constant Gardner
 
Top News arrow Testimony/Presentations
Testimonies and Presentations
Separating Science from Promotion, Evidence from Propaganda WCSJ 2009 Print E-mail
Sunday, 05 July 2009
Read more...
 
FDA Hearing. What FDA Failed to Disclose: 1991, 2006. Print E-mail
Saturday, 16 December 2006
AHRP Testimony presented by Vera Sharav, December 2006. PowerPoint slides (843 kb file).
 
A Multi-Headed Hydra Turned Medicine Into Snake Oil Print E-mail
Thursday, 16 November 2006
Presentation by Vera Sharav. NARPA Conference, Baltimore, MD. Nov. 17, 2006. PowerPoint slides (2.8 MB file).
 
National Plan for Universal Mental Health Screening:A Pharma Friendly Remedy for Societal Problems Print E-mail
Monday, 12 December 2005

Download the complete powerpoint presentation

Text of power point presentation:

Slide 2: I'll begin with the President's New Freedom Commission on Mental Health[1] recommendation to screen the US population for mental illness - 52 million children first. In no other democratic country has the government adopted a policy to screen the population for presumed, undetected, mental illness. The rationale behind this mind-boggling Orwellian nightmare is not improving mental health, but rather increasing life-long consumers of psychoactive drugs and to control behavior. Two NFC recommendations are designed to do just that. TeenScreen is promoted as a suicide prevention model when it in fact, increases the number of children labeled suicidal and depressed.

Read more...
 
America's Overmedicated Children, Presentation by Vera Sharav, Sweden Print E-mail
Wednesday, 01 June 2005

"Forgotten Children" is an investigative report by Carole Keeton Strayhorn,[1] the Texas Comptroller (2004) who uncovered evidence that 60% of children in the Texas foster care system are being drugged with powerful psychotropic drugs, most of which have not been tested in or approved for use by children. The Food and Drug Administration (FDA) acknowledges that many of these drugs have serious adverse side effects, both physical and psychological. The Comptroller said she was alarmed that in her review of a single month (November 2003), two powerful antipsychotic drugs -- Risperdal and Zyprexa -- made up half of the drugs prescribed to foster children in Texas. These two drugs have been approved only for adults for the treatment of psychosis - primarily schizophrenia - yet, she found that children as young as four, were receiving these powerful, mind-altering drugs.

Read more...
 
Testimony of Meryl Nass, MD - Senate HELP Committee, Subcommittee on Bioterrorism Print E-mail
Tuesday, 08 February 2005

Thank you for the opportunity to submit this testimony for the record.

My name is Meryl Nass, M.D., and I have worked for the past twenty years as an emergency physician and internist in community hospitals in the northeastern US. I have also studied many aspects of bioterrorism since 1989. I am the person who first demonstrated, in 1992, that one could investigate an epidemic retrospectively, and prove that it was due to biological warfare, using Rhodesia's 1978-80 anthrax epidemic as a model.[1]

Read more...
 
Best Pharmaceuticals for Children Act of 2002 Print E-mail
Monday, 18 August 2003

Comments submitted by The Alliance for Human Research Protection
to The National Academy of Sciences
Committee of the Institute of Medicine on Clinical Research Involving Children

AHRP has been closely monitoring pediatric research trends since passage of the FDA Modernization Act of 1997. We believe that medications used in children should be thoroughly tested for safety, effectiveness and appropriate dose. But unlike adults who can exercise their autonomous right to informed consent, children who are enrolled in clinical trials are non-consensual human subjects. They should not, therefore, be made to assume the burden of testing possibly toxic drugs whose safety is unknown.

Read more...
 
AHRP Testimonies re: Fatal ARDS Lung Experiment Print E-mail
Thursday, 26 June 2003

On June 10, 2003, a panel of experts convened by the federal Office of Human Research Protections (OHRP) heard presentations by critics who had filed complaints about $37 million government sponsored, multi-site experiment conducted by major academic institutions participating in the ARDSNetwork, and by the ARDSNet investigators who defend the trial.

The experiment tested two extreme, rarely used methods of mechanical lung ventilation in 861 critically ill, vulnerable patients suffering from acute lung disease (ALD) or acute respiratory distress syndrome (ARDS).

Read more...
 
<< Start < Prev 1 2 Next > End >>

Results 1 - 8 of 16
(C) 2014 Alliance for Human Research Protection

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]